Zheshang Securities(SH:601878) Xin Lang Cai Jing·2025-10-15 02:42Group 1 - The core point of the news is the significant increase in the stock price of Xingqi Eye Pharmaceutical, which rose by 5.1% to 69.02 CNY per share, with a trading volume of 399 million CNY and a turnover rate of 3.15%, leading to a total market capitalization of 16.934 billion CNY [1] Group 2 - Xingqi Eye Pharmaceutical, established on March 24, 1977, and listed on December 8, 2016, is located in Shenyang, Liaoning Province. The company specializes in the research, production, and sales of ophthalmic drugs [1] - The main business revenue composition of Xingqi Eye Pharmaceutical includes eye drops at 82.15%, gel/eye ointments at 16.70%, and other supplementary products at 1.15% [1] Group 3 - From the perspective of fund holdings, one fund under Zheshang Securities Asset Management has a significant position in Xingqi Eye Pharmaceutical. The Zheshang Huijin Transformation Driver fund (001540) held 33,300 shares in the second quarter, accounting for 3.18% of the fund's net value, ranking as the ninth largest holding [2] - The Zheshang Huijin Transformation Driver fund, established on July 27, 2015, has a latest scale of 54.3128 million CNY and has achieved a year-to-date return of 11.05%, ranking 5540 out of 8161 in its category [2] - The fund manager, Chen Gujun, has been in position for 5 years and 270 days, with a total asset scale of 204 million CNY. The best fund return during his tenure is 39.87%, while the worst is -7.57% [2]